These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36468316)
1. Pregnancy in homozygous familial hypercholesterolemia-A case series. Bláha M; Veletová K; Blaha V; Lánská M; Žák P Ther Apher Dial; 2022 Dec; 26 Suppl 1():89-96. PubMed ID: 36468316 [TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein apheresis: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505 [TBL] [Abstract][Full Text] [Related]
3. Complementary role of evinacumab in combination with lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Duell PB; Warden BA Ther Apher Dial; 2022 Dec; 26 Suppl 1():12-17. PubMed ID: 36468314 [TBL] [Abstract][Full Text] [Related]
4. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia. Du Z; Li F; Jiang L; Li L; Du Y; Yu H; Luo Y; Wang Y; Sun H; Hu C; Li J; Yang Y; Jiao X; Wang L; Qin Y BMC Med; 2023 Jul; 21(1):275. PubMed ID: 37501168 [TBL] [Abstract][Full Text] [Related]
5. A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study. Stefanutti C; Pang J; Di Giacomo S; Wu X; Wang X; Morozzi C; Watts GF; Lin J J Clin Lipidol; 2019; 13(4):608-617. PubMed ID: 31255589 [TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy. Vishwanath R; Hemphill LC J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684 [TBL] [Abstract][Full Text] [Related]
7. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]. Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575 [TBL] [Abstract][Full Text] [Related]
8. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Makino H; Harada-Shiba M Ther Apher Dial; 2003 Aug; 7(4):397-401. PubMed ID: 12887721 [TBL] [Abstract][Full Text] [Related]
9. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia. Lee WP; Datta BN; Ong BB; Rees A; Halcox J Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315 [TBL] [Abstract][Full Text] [Related]
10. Severe dyslipidemia in pregnancy: The role of therapeutic apheresis. Russi G Transfus Apher Sci; 2015 Dec; 53(3):283-7. PubMed ID: 26626968 [TBL] [Abstract][Full Text] [Related]
11. Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies. Botha TC; Pilcher GJ; Wolmarans K; Blom DJ; Raal FJ Atherosclerosis; 2018 Oct; 277():502-507. PubMed ID: 30270091 [TBL] [Abstract][Full Text] [Related]
12. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity. Klaus G; Taylan C; Büscher R; Schmitt CP; Pape L; Oh J; Driemeyer J; Galiano M; König J; Schürfeld C; Spitthöver R; Schaefer JR; Weber LT; Heibges A; Klingel R Pediatr Nephrol; 2018 Jul; 33(7):1199-1208. PubMed ID: 29502162 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis. Blaha M; Lanska M; Blaha V; Boudys L; Zak P Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317 [TBL] [Abstract][Full Text] [Related]
14. A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting. Blom DJ; Gaudet D; Hegele RA; Patel DS; Cegla J; Kolovou G; Marin LM Adv Ther; 2022 Apr; 39(4):1857-1870. PubMed ID: 35194765 [TBL] [Abstract][Full Text] [Related]
15. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures. van Buuren F; Kreickmann S; Horstkotte D; Kottmann T; Mellwig KP Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):24-30. PubMed ID: 22528135 [TBL] [Abstract][Full Text] [Related]
16. Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both? Schettler VJJ; Ringel J; Jacob S; Julius U; Klingel R; Heigl F; Roeseler E; Grützmacher P; Atheroscler Suppl; 2017 Nov; 30():44-49. PubMed ID: 29096860 [TBL] [Abstract][Full Text] [Related]
17. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia. Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070 [TBL] [Abstract][Full Text] [Related]
18. Homozygous familial hypercholesterolaemia: update on management. France M Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828 [TBL] [Abstract][Full Text] [Related]